Article
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study.
The oncologist - 17 Jan 2025
Schettini Francesco, Sirico Marianna, Loddo Marco, Williams Gareth H, Hardisty Keeda-Marie, Scorer Paul, Thatcher Robert, Rivera Pablo, Milani Manuela, Strina Carla, Ferrero Giuseppina, Ungari Marco, Bottin Cristina, Zanconati Fabrizio, de Manzini Nicolò, Aguggini Sergio, Tancredi Richard, Fiorio Elena, Fioravanti Antonio, Scaltriti Maurizio, Generali Daniele
Abstract excerpt
BACKGROUND: The identification of the most appropriate targeted therapies for advanced cancers is challenging. We performed a molecular profiling of metastatic solid tumors utilizing a comprehensive next-generation sequencing (NGS) assay to determine genomic alterations' type, frequency, actionability, and potential correlations with PD-L1 expression. METHODS: A total of 304 adult patients with heavily pretreated...
Topics
- Humans
- High-Throughput Nucleotide Sequencing
- Female
- Neoplasms
- Male
- Middle Aged
- Prospective Studies
- Aged
- Adult
